[1] Marks LB, Munley MT, Bentel GC, et al.  Physical and biological predictors of changes in whole-lung function following thoracic irradiation[J]. Int J Radiat Oncol Biol Phys, 1997, 39(3): 563-570.   doi: 10.1016/S0360-3016(97)00343-X
[2] Kwa SL, Lebesque JV, Theuws JC, et al.  Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients[J]. Int J Radiat Oncol Biol Phys, 1998, 42(1): 1-9.
[3] Fu XL, Huang H, Bentel G, et al.  Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta[J]. Int J Radiat Oncol Biol Phys, 2001, 50(4): 899-908.   doi: 10.1016/S0360-3016(01)01524-3
[4] Graham MV, Pajak TE, Herskovic AM, et al.  Phase I/II study of treatmentoflocally advanced(T3/T4)non-oatcelllung cancer with concomitant boost radiotherapy by the radiation therapy oncology group(RTOG 83-12): long-term results[J]. Int J Radiat Oncol Biol Phys, 1995, 31(4): 819-825.   doi: 10.1016/0360-3016(94)00543-5
[5] Komaki R, Lee JS, Milas L, et al.  Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-celllung cancer: reportofa randomized comparative trial[J]. Int J Radiat Oncol Biol Phys, 2004, 58(5): 1369-1377.   doi: 10.1016/j.ijrobp.2003.10.005
[6] Delaunois LM.  Mechanisms in pulmonary toxicology[J]. Clin Chest Med, 2004, 25(1): 1-14.   doi: 10.1016/S0272-5231(03)00122-9
[7] Vujaskovic Z, Groen HJ.  TGF-beta, radiation-induced pulmonary injury and lung cancer[J]. Int J Radiat Biol, 2000, 76(4): 511-516.
[8] 高春芳.  纤维化疾病的基础与临床[J]. 上海: 上海科学技术出版社, 2004, : 90-99.
[9] Ao X, Zhao L, Davis MA, et al.  Radiation produces differential changes in cytokine profiles in radiation lung fibrosis sensitive and resistantmice[J]. J Hematol Oncol, 2009, 2: 6-.   doi: 10.1186/1756-8722-2-6
[10] Yang K, Palm J, König J, et al.  Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury[J]. Int J Radiat Biol, 2007, 83(10): 665-676.   doi: 10.1080/09553000701558977
[11] Westermann W, Schobl R, Rieber EP, et al.  Th2 cells as effectors inpostirradiation pulmonary damage preceding fibrosis in the rat[J]. Int J Radiat Biol, 1999, 75(5): 629-638.
[12] Ghosh SN, Zhang R, Fish BL, et al.  Renin-angiotensin system suppression mitigates experimental radiation pneumonitis[J]. Int J Radiat Oncol Biol Phys, 2009, 75(5): 1528-1536.   doi: 10.1016/j.ijrobp.2009.07.1743
[13] Rossi SE, Erasmus JJ, McAdams HP, et al.  Pulmonary drug toxicity: radiologic and pathologic manifestations[J]. Radiographics, 2000, 20(5): 1245-1259.   doi: 10.1148/radiographics.20.5.g00se081245
[14] Erasmus JJ, McAdams HP, Rossi SE.  High-resolution CT of drug induced lung disease[J]. Radiol Clin North Am, 2002, 40(1): 61-72.   doi: 10.1016/S0033-8389(03)00109-X
[15] Movsas B, Raffin TA, Epstein AH, et al.  Pulmonary radiation injury[J]. Chest, 1997, 111(4): 1061-1076.   doi: 10.1378/chest.111.4.1061
[16] Trott KR, Herrmann T, Kasper M.  Target cells in radiation pneumopathy[J]. Int J Radiat Oncol Biol Phys, 2004, 58(2): 463-469.   doi: 10.1016/j.ijrobp.2003.09.045
[17] Pang QS, Wang P, Wang J, et al.  Basic research of the relationship between irradiation dose and volume in radiation-induced pulmonary injury[J]. Chin Med J(Engl), 2009, 122(16): 1929-1934.
[18] Müller G, Kiricuta IC, Stiess J, et al.  Radiation pneumonitis and pulmonary fibrosis after the CT-planned radiotherapy of bronchial carcinoma[J]. Strahlenther Onkol, 1994, 170(7): 400-407.
[19] Marks LB.  Dosimetric predictors of radiation-induced lung injury[J]. Int J Radiat Oncol Biol Phys, 2002, 54(2): 313-316.
[20] Willner J, JostA, Baier K, et al.  A little to a lotora lotto a little?An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy[J]. Strahlenther Onkol, 2003, 179(8): 548-556.   doi: 10.1007/s00066-003-1078-0
[21] 程文芳, 钱飞宇, 李云英.  肺癌放疗与放射性肺炎的研究[J]. 实用肿瘤学杂志, 2000, 14(4): 274-275.   doi: 10.3969/j.issn.1002-3070.2000.04.020
[22] Hernando ML, Marks LB, Bentel GC, et al.  Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer[J]. Int J Radiat Oncol Biol Phys, 2001, 51(3): 650-659.   doi: 10.1016/S0360-3016(01)01685-6
[23] Roach M 3rd, Gandara DR, Yuo HS, et al.  Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors[J]. J Clin Oncol, 1995, 13(10): 2606-2612.   doi: 10.1200/JCO.1995.13.10.2606
[24] RancatiT, CeresoliGL, GagliardiG, et al.  Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study[J]. Radiother Oncol, 2003, 67(3): 275-283.   doi: 10.1016/S0167-8140(03)00119-1
[25] Taghian AG, Assaad SI, Niemierko A, et al.  Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel[J]. J Natl Cancer Inst, 2001, 93(23): 1806-1811.   doi: 10.1093/jnci/93.23.1806
[26] Marks LB, Fan M, Clough R, et al.  Radiation-induced pulmonary injury: symptomatic versus subclinical endpoints[J]. Int J Radiat Biol, 2000, 76(4): 469-475.   doi: 10.1080/095530000138466
[27] Skoczylas JZ, Bentzen SM, Overgaard M, et al.  Time course of radiological lung density changes after postmastectomy radiotherapy[J]. Acta Oncol, 2000, 39(2): 181-187.   doi: 10.1080/028418600430743
[28] Koenig TR, Munden RF, Erasmus JJ, et al.  Radiation injury of the lung after three-dimensional conformal radiation therapy[J]. AJR Am J Roentgenol, 2002, 178(6): 1383-1388.   doi: 10.2214/ajr.178.6.1781383
[29] Song H, Yu JM, Kong FM, et al.  [18F]2-fluoro-2-deoxyglucose positron emission tomography/computed tomography in predicting radiation pneumonitis[J]. Chin Med J(Engl), 2009, 122(11): 1311-1315.
[30] Theuws JC, Seppenwoolde Y, Kwa SL, et al.  Changes in local pulmonary injury up to 48 months after irradiation for lymphoma and breast cancer[J]. Int J Radiat Oncol Biol Phys, 2000, 47(5): 1201-1208.   doi: 10.1016/S0360-3016(00)00546-0
[31] Woel RT, Munley MT, Hollis D, et al.  The time course of radiation therapy-induced reductions in regional perfusion: a prospective study with & gt; 5 years of follow-up[J]. Int J Radiat Oncol Biol Phys, 2002, 52(1): 58-67.   doi: 10.1016/S0360-3016(01)01809-0
[32] Moulder JE, Fish BL, Cohen EP.  Angiotensin II receptor antagonists in the treatment and prevention of radiation nephropathy[J]. Int J Radiat Biol, 1998, 73(4): 415-421.   doi: 10.1080/095530098142257
[33] Li M, Abdollahi A, Gröne HJ, et al.  Late treatment with imatinib mesylate ameliorates radiation-induced lung fibrosis in a mouse model[J]. Radiat Oncol, 2009, 4: 66-.